Death-Associated Protein Kinases
-
Subject Areas on Research
- Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
- De Novo Fragment Design for Drug Discovery and Chemical Biology.
- Death-associated protein kinase 1 promotes growth of p53-mutant cancers.
- Dual Ser and Thr phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by MYPT-associated kinase.
- Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells.
- Fluorescence linked enzyme chemoproteomic strategy for discovery of a potent and selective DAPK1 and ZIPK inhibitor.
- Identification of the endogenous smooth muscle myosin phosphatase-associated kinase.
- Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy.
- Phosphorylation-dependent control of ZIPK nuclear import is species specific.
- ROCK1 phosphorylates and activates zipper-interacting protein kinase.
- Regulation of death-associated protein kinase. Stabilization by HSP90 heterocomplexes.
- Smooth muscle myosin phosphatase-associated kinase induces Ca2+ sensitization via myosin phosphatase inhibition.
- Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of Serine 695 in response to cyclic nucleotides.
- Targeting Pim Kinases and DAPK3 to Control Hypertension.
- ZIP kinase, a key regulator of myosin protein phosphatase 1.